The circuit's reversal of the verdict was a win for defendant Boehringer Ingelheim Pharmaceuticals, which argued that federal law preempted plaintiff Betty Knight's state law claims that Boehringer failed to adequately warn about the risks of taking Pradaxa.
January 07, 2021 at 04:08 PM
1 minute read
The U.S. Court of Appeals for the Fourth Circuit on Thursday reversed a $1.25 million jury verdict awarded to the family of a deceased woman who claimed she suffered gastrointestinal bleeding as a result of taking the blood thinner Pradaxa.
The circuit’s reversal of the verdict was a win for defendant Boehringer Ingelheim Pharmaceuticals, which argued that federal law preempted plaintiff Betty Knight’s state law claims that Boehringer failed to adequately warn about the risks of taking Pradaxa.
Presented by BigVoodoo
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Pradaxa
